Logo image of ALKOM.PA

PLASTICOS COMPUESTOS SA (ALKOM.PA) Stock Fundamental Analysis

EPA:ALKOM - ES0105425005 - Common Stock

1.1 EUR
0 (0%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

2

Overall ALKOM gets a fundamental rating of 2 out of 10. We evaluated ALKOM against 0 industry peers in the Unkown industry. ALKOM has a bad profitability rating. Also its financial health evaluation is rather negative. ALKOM has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ALKOM had negative earnings in the past year.
ALKOM had a positive operating cash flow in the past year.
In the past 5 years ALKOM always reported negative net income.
In the past 5 years ALKOM always reported a positive cash flow from operatings.
ALKOM.PA Yearly Net Income VS EBIT VS OCF VS FCFALKOM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M 2M -2M

1.2 Ratios

Industry RankSector Rank
ROA -0.49%
ROE -1.21%
ROIC 4.34%
ROA(3y)-1.45%
ROA(5y)-1.83%
ROE(3y)-4.01%
ROE(5y)-4.99%
ROIC(3y)N/A
ROIC(5y)N/A
ALKOM.PA Yearly ROA, ROE, ROICALKOM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10

1.3 Margins

In the last couple of years the Operating Margin of ALKOM has declined.
ALKOM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.8%
PM (TTM) N/A
GM 17.28%
OM growth 3Y43.28%
OM growth 5Y-1.58%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.72%
GM growth 5Y2.56%
ALKOM.PA Yearly Profit, Operating, Gross MarginsALKOM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

More info and screens

1

2. Health

2.1 Basic Checks

ALKOM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for ALKOM has been increased compared to 1 year ago.
Compared to 5 years ago, ALKOM has less shares outstanding
Compared to 1 year ago, ALKOM has an improved debt to assets ratio.
ALKOM.PA Yearly Shares OutstandingALKOM.PA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALKOM.PA Yearly Total Debt VS Total AssetsALKOM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

ALKOM has an Altman-Z score of 1.70. This is a bad value and indicates that ALKOM is not financially healthy and even has some risk of bankruptcy.
ALKOM has a debt to FCF ratio of 7.12. This is a slightly negative value and a sign of low solvency as ALKOM would need 7.12 years to pay back of all of its debts.
A Debt/Equity ratio of 0.24 indicates that ALKOM is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 7.12
Altman-Z 1.7
ROIC/WACC0.41
WACC10.63%
ALKOM.PA Yearly LT Debt VS Equity VS FCFALKOM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

A Current Ratio of 0.86 indicates that ALKOM may have some problems paying its short term obligations.
ALKOM has a Quick Ratio of 0.86. This is a bad value and indicates that ALKOM is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.27
ALKOM.PA Yearly Current Assets VS Current LiabilitesALKOM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

3

3. Growth

3.1 Past

ALKOM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -33.00%.
The Revenue has decreased by -4.71% in the past year.
Measured over the past years, ALKOM shows a decrease in Revenue. The Revenue has been decreasing by -0.98% on average per year.
EPS 1Y (TTM)-33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.04%
Revenue 1Y (TTM)-4.71%
Revenue growth 3Y-9.25%
Revenue growth 5Y-0.98%
Sales Q2Q%3.27%

3.2 Future

Based on estimates for the next years, ALKOM will show a very strong growth in Earnings Per Share. The EPS will grow by 91.49% on average per year.
The Revenue is expected to grow by 5.18% on average over the next years.
EPS Next Y122.22%
EPS Next 2Y91.49%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.52%
Revenue Next 2Y5.18%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALKOM.PA Yearly Revenue VS EstimatesALKOM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
ALKOM.PA Yearly EPS VS EstimatesALKOM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2022 2023 2024 2025 2026 0 0.05 0.1 0.15 0.2

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

ALKOM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 10.89, the valuation of ALKOM can be described as reasonable.
ALKOM's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.69.
Industry RankSector Rank
PE N/A
Fwd PE 10.89
ALKOM.PA Price Earnings VS Forward Price EarningsALKOM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80 -100

4.2 Price Multiples

Industry RankSector Rank
P/FCF 12.52
EV/EBITDA 4.91
ALKOM.PA Per share dataALKOM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALKOM's earnings are expected to grow with 91.49% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y91.49%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALKOM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PLASTICOS COMPUESTOS SA

EPA:ALKOM (9/5/2025, 7:00:00 PM)

1.1

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.31%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap13.38M
Analysts84
Price Target2.18 (98.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-33.33%
EPS NY rev (3m)-33.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.39%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.89
P/S 0.3
P/FCF 12.52
P/OCF 6
P/B 1.01
P/tB 1.29
EV/EBITDA 4.91
EPS(TTM)-0.01
EYN/A
EPS(NY)0.1
Fwd EY9.18%
FCF(TTM)0.09
FCFY7.99%
OCF(TTM)0.18
OCFY16.66%
SpS3.62
BVpS1.09
TBVpS0.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.49%
ROE -1.21%
ROCE 5.9%
ROIC 4.34%
ROICexc 4.8%
ROICexgc 5.65%
OM 2.8%
PM (TTM) N/A
GM 17.28%
FCFM 2.43%
ROA(3y)-1.45%
ROA(5y)-1.83%
ROE(3y)-4.01%
ROE(5y)-4.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y37.08%
ROICexcg growth 5Y2.72%
ROICexc growth 3Y38.52%
ROICexc growth 5Y2.66%
OM growth 3Y43.28%
OM growth 5Y-1.58%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.72%
GM growth 5Y2.56%
F-Score4
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 7.12
Debt/EBITDA 0.84
Cap/Depr 46.86%
Cap/Sales 2.64%
Interest Coverage 0.86
Cash Conversion 60.12%
Profit Quality N/A
Current Ratio 0.86
Quick Ratio 0.27
Altman-Z 1.7
F-Score4
WACC10.63%
ROIC/WACC0.41
Cap/Depr(3y)31.27%
Cap/Depr(5y)45.34%
Cap/Sales(3y)1.84%
Cap/Sales(5y)2.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.04%
EPS Next Y122.22%
EPS Next 2Y91.49%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.71%
Revenue growth 3Y-9.25%
Revenue growth 5Y-0.98%
Sales Q2Q%3.27%
Revenue Next Year5.52%
Revenue Next 2Y5.18%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-10.28%
EBIT growth 3Y30.02%
EBIT growth 5Y-2.54%
EBIT Next Year173.65%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y59.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.81%
OCF growth 3Y56.63%
OCF growth 5Y-0.01%